Impact of the metabolic syndrome on the clinical outcome of patients with acute ST-elevation myocardial infarction

Journal of Korean Medical Science

Volumn 25, Issue 10, 2010, Pages 1456-1461

  Lee, Min Goo ^a   Jeong, Myung Ho ^a   Ahn, Youngkeun ^a   Chae, Shung Chull ^b   Hur, Seung Ho ^c   Hong, Taek Jong ^d   Kim, Young Jo ^e   Seong, In Whan ^f   Chae, Jei Keon ^g   Rhew, Jay Young ^h   Chae, In Ho ⁱ   Cho, Myeong Chan ^j   Bae, Jang Ho ^k   Rha, Seung Woon ^l   Kim, Chong Jin ^m   Choi, Donghoon ⁿ   Jang, Yang Soo ⁿ   Yoon, Junghan ^o   Chung, Wook Sung ^p   Cho, Jeong Gwan ^a   Seung, Ki Bae ^p   Park, Seung Jung ^q   more..

^a Chonnam National University Medical School   (South Korea)

^b Kyungpook National University   (South Korea)

^c Dongsan Medical Center   (South Korea)

^d Pusan National University Hospital   (South Korea)

^e Young Nam University Hospital   (South Korea)

^f Chungnam National University College of Medicine   (South Korea)

^g Chonbuk National University Medical School   (South Korea)

^h Jeonju Presbyterian Medical Center   (South Korea)

ⁱ Seoul National University Bundang Hospital   (South Korea)

^j Chungbuk National University   (South Korea)

^k Konyang University   (South Korea)

^l Korea University College of Medicine   (South Korea)

^m Kyung Hee University College of Medicine   (South Korea)

ⁿ Yonsei University   (South Korea)

^o Wonju Severance Christian Hospital   (South Korea)

^p The Catholic University of Korea   (South Korea)

^q Asan Medical Center   (South Korea)

more..

Author keywords

Metabolic syndrome; Myocardial infarction; Prognosis

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE DISEASE; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; TREATMENT OUTCOME;

ACUTE DISEASE; AGE FACTORS; AGED; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 78449300894     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.10.1456     Document Type: Article

References (28)

1. Ferrannini E, Hafner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-22.
2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
3. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-16.
4. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Hafner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414-9.
5. Cha BS, Kim HJ. Metabolic syndrome and cardiovascular disease. Korean Circ J 2003; 33: 645-52.
6. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005; 112: 2735-52.
7. Rantala AO, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesaniemi YA. Prevalence of the metabolic syndrome in drug-treated hypertension patients and control subjects. J Intern Med 1999; 245: 163-74.
8. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-9.
9. Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lésperance J, Lévesque S, Varga S. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angio-graphic severity. Am J Cardiol 2004; 93: 159-64.
10. Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL; for the SMART Study Group. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2004; 25: 342-8.
11. Girman CJ, Rhodes T, Mercuri M, Pyörälä K, Kjekshus J, Pedersen TR, Beere PA, Gotto AM, Clearfield M; 4S Group and the AFCAPS/TexCAPS Research Group. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/Tex-CAPS). Am J Cardiol 2004; 93: 136-41.
12. Lee KH, Jeong MH, Ahn YK, Kim YJ, Chae SC, Hong TJ, Seong IW, Chae JK, Kim CJ, Cho MC, Seung KB, Park SJ; other Korea Acute Myocardial Infarction Registry Investigators. Gender differences of success rate of percutaneous coronary intervention and short term cardiac events in Korea Acute Myocardial Infarction Registry. Int J Cardiol 2008; 130: 227-34.
13. Sim DS, Jeong MH, Ahn YK, Kim YJ, Chae SC, Hong TJ, Seong IW, Chae JK, Kim CJ, Cho MC, Seung KB, Park SJ; Korea Acute Myocardial Infarction Registry (KAMIR) Investigators. Safety and benefit of early elective percutaneous coronary inter vention after successful thrombolytic therapy for acute myocardial infarction. Am J Cardiol 2009; 103: 1333-8.
14. French JK, White HD. Clinical implications of the new definition of myocardial infarction. Heart 2004; 90: 99-106.
15. Kini AS. Coronary angiography, lesion classification and severity assessment. Cardiol Clin 2006; 24: 153-62.
16. Manginas A, Gatzov P, Chasikidis C, Voudris V, Pavlides G, Cokkinos DV. Estimation of coronary flow reserve using the Trombolysis In Myocardial Infarction (TIMI) frame count method. Am J Cardiol 1999; 83: 1562-5.
17. Kahn R. Metabolic syndrome: is it a syndrome? Does it matter? Circulation 2007; 115: 1806-11.
18. Gale EA. Should we dump the metabolic syndrome? Yes. BMJ 2008; 336: 640.
19. Levantesi G, Macchia A, Marfisi R, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; GISSI-Prevenzione Investigators. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol 2005; 46: 277-83.
20. Zeller M, Steg PG, Ravisy J, Laurent Y, Janin-Manificat L, L'Huillier I, Beer JC, Oudot A, Rioufol G, Makki H, Farnier M, Rochette L, Vergès B, Cottin Y; Observatoire des Infarctus de Cote-d́Or Survey Working Group. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med 2005; 165: 1192-8.
21. Yudkin JS, Juhan-Vague I, Hawe E, Humphries SE, di Minno G, Margaglione M, Tremoli E, Kooistra T, Morange PE, Lundman P, Mohamed-Ali V, Hamsten A; HIFMECH Study Group. Low grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 2004; 53: 852-7.
22. Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Rydén L. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004; 25: 1990-7.
23. Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA; American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004; 109: 551-6.
24. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
25. Wannamethee SG, Shaper AG, Morris RW, Whincup PH. Measures of adiposity in the identification of metabolic abnormalities in elderly men. Am J Clin Nutr 2005; 81: 1313-21.
26. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-74.
27. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995; 331: 158-61.
28. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ, Reis SE. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) Study. Circulation 2004; 109: 706-13.